Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Update on Sale of decommissioned unit
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma is selling a decommissioned manufacturing unit located at A-159, MIDC, Wagle Industrial Estate, Thane, to Global Pharma for approximately Rs. 8.50 Crores plus applicable taxes. The company's Administrative Committee approved the sale deed and related agreements on 22nd July 2025, and the deal is expected to close within 90 days subject to conditions in the sale deed. An earlier Memorandum of Understanding with a different party, signed earlier in the year, has been terminated for commercial reasons. The unit contributed nil to the company's turnover, income, and net worth in the last financial year, so the sale will have no impact on operations. The buyer is unrelated to the promoter/promoter group and the deal is not a related-party transaction.
The transaction is financially immaterial and is essentially a cleanup of a non-operational, decommissioned asset. Shareholders should not expect any meaningful change in revenue, profitability, or stock price from this sale.